The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients (NCT06295848) | Clinical Trial Compass
CompletedNot Applicable
The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients
Turkey (Türkiye)40 participantsStarted 2022-11-15
Plain-language summary
The aim of this study is to investigate the beneficial impacts of the 6-week standardized CR program applied to hypertensive RA patients whose disease activity is under control with regular pharmacological treatment.
Subjects will be randomly assigned to one of two groups: 1.) standard of care (SOC) treatment or 2.) SOC plus a 6 week CR program.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Patients diagnosed with RA according to ACR/EULAR 2010 criteria
. Taking regular treatment for at least 1 month according to ACR/EULAR guidelines
. Patients diagnosed with HT according to the 2018 European Society of Hypertension and European Society of Cardiology (ESH/ESC) guideline
Exclusion criteria
. Refusing to participate in the program
. Severe mental disorder
. Neurological disease or deformity in the lower extremity that would prevent the patient from using the treadmill.
. High-risk unstable angina and all acute cardiac diseases (acute myocardial infarction, acute endocarditis, myocarditis or pericarditis)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial studied people who have both rheumatoid arthritis and high blood pressure together — since I have these conditions, is a cardiac rehabilitation programme something my care team would consider appropriate for me, given how my RA and blood pressure are currently controlled?
2The trial measured the Framingham Risk Score and QRISK-3, which are tools for estimating heart disease risk — could you run these scores for me so we can see where I stand and whether a structured cardiac rehab approach might meaningfully change my cardiovascular risk?
3The study tracked DAS28 alongside heart health markers, suggesting a link between RA disease activity and cardiovascular outcomes — how active is my RA right now, and could better managing my RA inflammation also help lower my heart risk?
4The trial measured VO2max, which reflects how well the heart and lungs work during exercise — given my current fitness level and any joint limitations from RA, what kind of exercise programme would actually be safe and realistic for me to follow?
5Since this trial has already been completed, would you be able to share or look up any published results from it, and based on those findings, is there a similar cardiac rehabilitation programme available to me through my current healthcare provider?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.